RFA-Announcement of a Limited Competition for the Continuation of the Nuclear Receptor Signaling Atlas (U19)
The summary for the RFA-Announcement of a Limited Competition for the Continuation of the Nuclear Receptor Signaling Atlas (U19) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
RFA-Announcement of a Limited Competition for the Continuation of the Nuclear Receptor Signaling Atlas (U19): The National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, the National Heart, Lung and Blood Institute, the National Institute of Environmental Health Sciences, and the National Institute of Child Health and Human Development invite a competing continuation application to participate in a trans-NIH consortium to complete the development and implementation of an Atlas of Nuclear Hormone Receptors. The main objective will be to accrue, develop, analyze, and communicate information on the role(s) of Nuclear Hormone Receptors (NHR) in health and disease and to design studies with immediate translational impact on human disease, to catalyze the translation of basic knowledge into approaches that will help to understand and treat disease. The NIDDK and co-sponsoring NIH partners will commit $2.85M Total Costs to fund one award for up to five years.
Federal Grant Title: | RFA-Announcement of a Limited Competition for the Continuation of the Nuclear Receptor Signaling Atlas (U19) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DK-06-503 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.11693.837 |
CFDA Descriptions: | Project Grants and Cooperative Agreements for Tuberculosis Control Programs 93.837 Heart and Vascular Diseases Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Dec 16, 2006 |
Posted Date: | Oct 18, 2006 |
Creation Date: | Oct 18, 2006 |
Archive Date: | Jan 15, 2007 |
Total Program Funding: | $2,850,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | 93.847 -- Diabetes, Endocrinology and Metabolism Research |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. You may submit an application if your organization received a Notice of Grant Award (U19 DK62434) for the Functional Atlas of Orphan Nuclear Receptors. NOTE: Foreign institutions are not eligible to apply. Investigators from foreign institutions may participate as a component of an application submitted by a PI from an institution within the United States of America
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster